<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2000-12-01" modified="2020-10-07" version="191">
<accession>Q13291</accession>
<accession>Q5W172</accession>
<accession>Q9HBE8</accession>
<accession>W0HKK7</accession>
<name>SLAF1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Signaling lymphocytic activation molecule</fullName>
</recommendedName>
<alternativeName>
<fullName>CDw150</fullName>
</alternativeName>
<alternativeName>
<fullName>IPO-3</fullName>
</alternativeName>
<alternativeName>
<fullName>SLAM family member 1</fullName>
</alternativeName>
<cdAntigenName>CD150</cdAntigenName>
</protein>
<gene>
<name type="primary">SLAMF1</name>
<name type="synonym">SLAM</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="Nature" volume="376" first="260" last="263">
<title>A novel receptor involved in T-cell activation.</title>
<authorList>
<person name="Cocks B.G."/>
<person name="Chang C.-C.J."/>
<person name="Carballido J.M."/>
<person name="Yssel H."/>
<person name="de Vries J.E."/>
<person name="Aversa G."/>
</authorList>
<dbReference type="PubMed" id="7617038"/>
<dbReference type="DOI" id="10.1038/376260a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2015" name="PLoS ONE" volume="10" first="E0118302" last="E0118302">
<title>Expression of CD150 in tumors of the central nervous system: identification of a novel isoform.</title>
<authorList>
<person name="Romanets-Korbut O."/>
<person name="Najakshin A.M."/>
<person name="Yurchenko M."/>
<person name="Malysheva T.A."/>
<person name="Kovalevska L."/>
<person name="Shlapatska L.M."/>
<person name="Zozulya Y.A."/>
<person name="Taranin A.V."/>
<person name="Horvat B."/>
<person name="Sidorenko S.P."/>
</authorList>
<dbReference type="PubMed" id="25710480"/>
<dbReference type="DOI" id="10.1371/journal.pone.0118302"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4)</scope>
<scope>FUNCTION (MICROBIAL INFECTION) (ISOFORM 4)</scope>
<scope>TISSUE SPECIFICITY (ISOFORM 4)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM 4)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2003" name="J. Med. Virol." volume="70" first="131" last="136">
<title>Absence of SLAM mutations in EBV-associated lymphoproliferative disease patients.</title>
<authorList>
<person name="Ferrand V."/>
<person name="Li C."/>
<person name="Romeo G."/>
<person name="Yin L."/>
</authorList>
<dbReference type="PubMed" id="12629654"/>
<dbReference type="DOI" id="10.1002/jmv.10373"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 265-288</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1997" name="J. Exp. Med." volume="185" first="993" last="1004">
<title>Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes.</title>
<authorList>
<person name="Punnonen J."/>
<person name="Cocks B.G."/>
<person name="Carballido J.M."/>
<person name="Bennett B."/>
<person name="Peterson D."/>
<person name="Aversa G."/>
<person name="de Vries J.E."/>
</authorList>
<dbReference type="PubMed" id="9091591"/>
<dbReference type="DOI" id="10.1084/jem.185.6.993"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1998" name="Nature" volume="395" first="462" last="469">
<title>The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM.</title>
<authorList>
<person name="Sayos J."/>
<person name="Wu C."/>
<person name="Morra M."/>
<person name="Wang N."/>
<person name="Zhang X."/>
<person name="Allen D."/>
<person name="van Schaik S."/>
<person name="Notarangelo L."/>
<person name="Geha R."/>
<person name="Roncarolo M.G."/>
<person name="Oettgen H."/>
<person name="de Vries J.E."/>
<person name="Aversa G."/>
<person name="Terhorst C."/>
</authorList>
<dbReference type="PubMed" id="9774102"/>
<dbReference type="DOI" id="10.1038/26683"/>
</citation>
<scope>INTERACTION WITH SH2D1A</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1999" name="J. Immunol." volume="162" first="5719" last="5727">
<title>CDw150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis.</title>
<authorList>
<person name="Mikhalap S.V."/>
<person name="Shlapatska L.M."/>
<person name="Berdova A.G."/>
<person name="Law C.L."/>
<person name="Clark E.A."/>
<person name="Sidorenko S.P."/>
</authorList>
<dbReference type="PubMed" id="10229804"/>
</citation>
<scope>INTERACTION WITH INPP5D</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2000" name="Nature" volume="406" first="893" last="897">
<title>SLAM (CDw150) is a cellular receptor for measles virus.</title>
<authorList>
<person name="Tatsuo H."/>
<person name="Ono N."/>
<person name="Tanaka K."/>
<person name="Yanagi Y."/>
</authorList>
<dbReference type="PubMed" id="10972291"/>
<dbReference type="DOI" id="10.1038/35022579"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH MEASLES VIRUS HN PROTEIN</scope>
<scope>DOMAIN IG-LIKE V-TYPE</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2001" name="J. Immunol." volume="166" first="5480" last="5487">
<title>CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A.</title>
<authorList>
<person name="Shlapatska L.M."/>
<person name="Mikhalap S.V."/>
<person name="Berdova A.G."/>
<person name="Zelensky O.M."/>
<person name="Yun T.J."/>
<person name="Nichols K.E."/>
<person name="Clark E.A."/>
<person name="Sidorenko S.P."/>
</authorList>
<dbReference type="PubMed" id="11313386"/>
<dbReference type="DOI" id="10.4049/jimmunol.166.9.5480"/>
</citation>
<scope>INTERACTION WITH INPP5D; PTPN11 AND SH2D1A</scope>
<scope>MUTAGENESIS OF TYR-269; TYR-281; TYR-307 AND TYR-327</scope>
<scope>DOMAIN ITSM MOTIF</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="Blood" volume="99" first="957" last="965">
<title>Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated costimulation.</title>
<authorList>
<person name="Howie D."/>
<person name="Simarro M."/>
<person name="Sayos J."/>
<person name="Guirado M."/>
<person name="Sancho J."/>
<person name="Terhorst C."/>
</authorList>
<dbReference type="PubMed" id="11806999"/>
<dbReference type="DOI" id="10.1182/blood.v99.3.957"/>
</citation>
<scope>INTERACTION WITH SH2D1A</scope>
<scope>PHOSPHORYLATION AT TYR-281; TYR-307 AND TYR-327</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF THR-279; TYR-281; THR-325 AND TYR-327</scope>
<scope>DOMAIN ITSM MOTIF</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="3852" last="3859">
<title>Dual functional roles for the X-linked lymphoproliferative syndrome gene product SAP/SH2D1A in signaling through the signaling lymphocyte activation molecule (SLAM) family of immune receptors.</title>
<authorList>
<person name="Li C."/>
<person name="Iosef C."/>
<person name="Jia C.Y."/>
<person name="Han V.K."/>
<person name="Li S.S."/>
</authorList>
<dbReference type="PubMed" id="12458214"/>
<dbReference type="DOI" id="10.1074/jbc.m206649200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SH2D1A; SH2D1B; INPP5D; PTPN11 AND FYN</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Blood" volume="107" first="2821" last="2829">
<title>SLAM/SLAM interactions inhibit CD40-induced production of inflammatory cytokines in monocyte-derived dendritic cells.</title>
<authorList>
<person name="Rethi B."/>
<person name="Gogolak P."/>
<person name="Szatmari I."/>
<person name="Veres A."/>
<person name="Erdos E."/>
<person name="Nagy L."/>
<person name="Rajnavoelgyi E."/>
<person name="Terhorst C."/>
<person name="Lanyi A."/>
</authorList>
<dbReference type="PubMed" id="16317102"/>
<dbReference type="DOI" id="10.1182/blood-2005-06-2265"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2010" name="Immunol. Cell Biol." volume="88" first="565" last="574">
<title>CD150 regulates JNK1/2 activation in normal and Hodgkin's lymphoma B cells.</title>
<authorList>
<person name="Yurchenko M.Y."/>
<person name="Kovalevska L.M."/>
<person name="Shlapatska L.M."/>
<person name="Berdova G.G."/>
<person name="Clark E.A."/>
<person name="Sidorenko S.P."/>
</authorList>
<dbReference type="PubMed" id="20231852"/>
<dbReference type="DOI" id="10.1038/icb.2010.14"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MAP4K1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2010" name="Nat. Immunol." volume="11" first="920" last="927">
<title>SLAM is a microbial sensor that regulates bacterial phagosome functions in macrophages.</title>
<authorList>
<person name="Berger S.B."/>
<person name="Romero X."/>
<person name="Ma C."/>
<person name="Wang G."/>
<person name="Faubion W.A."/>
<person name="Liao G."/>
<person name="Compeer E."/>
<person name="Keszei M."/>
<person name="Rameh L."/>
<person name="Wang N."/>
<person name="Boes M."/>
<person name="Regueiro J.R."/>
<person name="Reinecker H.C."/>
<person name="Terhorst C."/>
</authorList>
<dbReference type="PubMed" id="20818396"/>
<dbReference type="DOI" id="10.1038/ni.1931"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH BECN1 AND PIK3C3</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2001" name="EMBO J." volume="20" first="5840" last="5852">
<title>Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells.</title>
<authorList>
<person name="Morra M."/>
<person name="Lu J."/>
<person name="Poy F."/>
<person name="Martin M."/>
<person name="Sayos J."/>
<person name="Calpe S."/>
<person name="Gullo C."/>
<person name="Howie D."/>
<person name="Rietdijk S."/>
<person name="Thompson A."/>
<person name="Coyle A.J."/>
<person name="Denny C."/>
<person name="Yaffe M.B."/>
<person name="Engel P."/>
<person name="Eck M.J."/>
<person name="Terhorst C."/>
</authorList>
<dbReference type="PubMed" id="11689425"/>
<dbReference type="DOI" id="10.1093/emboj/20.21.5840"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 273-286 IN COMPLEX WITH SH2D1B</scope>
<scope>INTERACTION WITH SH2D1B</scope>
<scope>PHOSPHORYLATION AT TYR-281</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2002" name="EMBO J." volume="21" first="314" last="323">
<title>A 'three-pronged' binding mechanism for the SAP/SH2D1A SH2 domain: structural basis and relevance to the XLP syndrome.</title>
<authorList>
<person name="Hwang P.M."/>
<person name="Li C."/>
<person name="Morra M."/>
<person name="Lillywhite J."/>
<person name="Muhandiram D.R."/>
<person name="Gertler F."/>
<person name="Terhorst C."/>
<person name="Kay L.E."/>
<person name="Pawson T."/>
<person name="Forman-Kay J.D."/>
<person name="Li S.-C."/>
</authorList>
<dbReference type="PubMed" id="11823424"/>
<dbReference type="DOI" id="10.1093/emboj/21.3.314"/>
</citation>
<scope>STRUCTURE BY NMR OF 276-282 IN COMPLEX WITH SH2D1A</scope>
<scope>DOMAIN ITSM MOTIF</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2003" name="Nat. Cell Biol." volume="5" first="155" last="160">
<title>SAP couples Fyn to SLAM immune receptors.</title>
<authorList>
<person name="Chan B."/>
<person name="Lanyi A."/>
<person name="Song H.K."/>
<person name="Griesbach J."/>
<person name="Simarro-Grande M."/>
<person name="Poy F."/>
<person name="Howie D."/>
<person name="Sumegi J."/>
<person name="Terhorst C."/>
<person name="Eck M.J."/>
</authorList>
<dbReference type="PubMed" id="12545174"/>
<dbReference type="DOI" id="10.1038/ncb920"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 276-286 IN COMPLEX WITH SH2D1A AND FYN</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] PHE-81</scope>
</reference>
<comment type="function">
<text evidence="2 12 14 15 23 24">Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo- or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response. Activities are controlled by presence or absence of small cytoplasmic adapter proteins, SH2D1A/SAP and/or SH2D1B/EAT-2. SLAMF1-induced signal-transduction events in T-lymphocytes are different from those in B-cells. Two modes of SLAMF1 signaling seem to exist: one depending on SH2D1A (and perhaps SH2D1B) and another in which protein-tyrosine phosphatase 2C (PTPN11)-dependent signal transduction operates. Initially it has been proposed that association with SH2D1A prevents binding to inhibitory effectors including INPP5D/SHIP1 and PTPN11/SHP-2 (PubMed:11806999). However, signaling is also regulated by SH2D1A which can simultaneously interact with and recruit FYN which subsequently phosphorylates and activates SLAMF1 (PubMed:12458214). Mediates IL-2-independent proliferation of activated T-cells during immune responses and induces IFN-gamma production (By similarity). Downstreaming signaling involves INPP5D, DOK1 and DOK2 leading to inhibited IFN-gamma production in T-cells, and PRKCQ, BCL10 and NFKB1 leading to increased T-cell activation and Th2 cytokine production (By similarity). Promotes T-cell receptor-induced IL-4 secretion by CD4(+) cells (By similarity). Inhibits antigen receptor-mediated production of IFN-gamma, but not IL-2, in CD4(-)/CD8(-) T-cells (By similarity). Required for IL-4 production by germinal centers T follicular helper (T(Fh))cells (By similarity). May inhibit CD40-induced signal transduction in monocyte-derived dendritic cells (PubMed:16317102). May play a role in allergic responses and may regulate allergen-induced Th2 cytokine and Th1 cytokine secretion (By similarity). In conjunction with SLAMF6 controls the transition between positive selection and the subsequent expansion and differentiation of the thymocytic natural killer T (NKT) cell lineage. Involved in the peripheral differentiation of indifferent natural killer T (iNKT) cells toward a regulatory NKT2 type (By similarity). In macrophages involved in down-regulation of IL-12, TNF-alpha and nitric oxide in response to lipopolysaccharide (LPS) (By similarity). In B-cells activates the ERK signaling pathway independently of SH2D1A but implicating both, SYK and INPP5D, and activates Akt signaling dependent on SYK and SH2D1A (By similarity). In B-cells also activates p38 MAPK and JNK1 and JNK2 (PubMed:20231852). In conjunction with CD84/SLAMF5 and SLAMF6 may be a negative regulator of the humoral immune response (By similarity). Involved in innate immune response against Gram-negative bacteria in macrophages; probably recognizes OmpC and/or OmpF on the bacterial surface, regulates phagosome maturation and recruitment of the PI3K complex II (PI3KC3-C2) leading to accumulation of PdtIns(3)P and NOX2 activity in the phagosomes (PubMed:20818396).</text>
</comment>
<comment type="function">
<text evidence="5 16">(Microbial infection) Acts as a receptor for Measles virus; also including isoform 4.</text>
</comment>
<comment type="subunit">
<text evidence="6 7 8 9 10 11 14 15 19">Interacts (via cytoplasmic domain) with SH2D1A and SH2D1B; SH2D1A mediates association with FYN; SH2D1A binds to phosphorylated and not phosphorylated ITSM 1 (PubMed:9774102, PubMed:11313386, PubMed:11806999, PubMed:12458214). Interacts (via cytoplasmic domain phosphorylated on tyrosine residues) with INPP5D and PTPN11; presence of SH2D1A facilitates binding to INPP5D (PubMed:11313386, PubMed:12458214). Interacts with MAP4K1 (PubMed:20231852). Interacts with PIK3C3, BECN1 and UVRAG; indicative for an association with PI3K complex II (PI3KC3-C2) (PubMed:20818396).</text>
</comment>
<comment type="subunit">
<text evidence="5">(Microbial infection) Interacts with measles hemagglutinin protein.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4315002">
<id>Q13291</id>
</interactant>
<interactant intactId="EBI-881">
<id>Q92918</id>
<label>MAP4K1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4315002">
<id>Q13291</id>
</interactant>
<interactant intactId="EBI-6983382">
<id>O60880</id>
<label>SH2D1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4315002">
<id>Q13291</id>
</interactant>
<interactant intactId="EBI-15552052">
<id>O60880-1</id>
<label>SH2D1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4315002">
<id>Q13291</id>
</interactant>
<interactant intactId="EBI-4315002">
<id>Q13291</id>
<label>SLAMF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4315002">
<id>Q13291</id>
</interactant>
<interactant intactId="EBI-5323300">
<id>Q786F2</id>
<label>H</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="8">Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<text evidence="8">Present on the surface of B-cells and T-cells. Located at the plasma membrane contacts between neighboring T-cells (PubMed:11806999).</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 3</molecule>
<subcellularLocation>
<location evidence="26">Secreted</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 4</molecule>
<subcellularLocation>
<location evidence="25">Cell membrane</location>
</subcellularLocation>
<text evidence="16">Overexpressed isoform 4 is detected on the cell surface. In glioma cell lines endogenuous isoform 4 is detetced predominantly in the cytoplasm and colocalized with endoplasmic reticulum and Golgi markers.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q13291-1</id>
<name>1</name>
<name>Long</name>
<name>mCD150</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q13291-2</id>
<name>2</name>
<name>Short</name>
<name>SURslam2</name>
<name>vmSLAM</name>
<sequence type="described" ref="VSP_002568 VSP_002569"/>
</isoform>
<isoform>
<id>Q13291-3</id>
<name>3</name>
<name>Secreted</name>
<name>SECslam</name>
<name>sSLAM</name>
<sequence type="described" ref="VSP_002567"/>
</isoform>
<isoform>
<id>Q13291-4</id>
<name>4</name>
<name>nCD150</name>
<sequence type="described" ref="VSP_058033"/>
</isoform>
<text>Additional isoforms seem to exist.</text>
</comment>
<comment type="tissue specificity">
<text evidence="16 17 18">Constitutively expressed on peripheral blood memory T-cells, T-cell clones, immature thymocytes and a proportion of B-cells, and is rapidly induced on naive T-cells after activation (PubMed:7617038). Activated B-cells express isoform 1, isoform 3 and a cytoplasmic isoform (PubMed:9091591). Isoform 4 is expressed in B-cells, primary T-cells, dendritic cells and macrophages. Isoform 4 is expressed in tumors of the central nervous system (PubMed:25710480).</text>
</comment>
<comment type="domain">
<text evidence="8 9 22">The ITSMs (immunoreceptor tyrosine-based switch motifs) with the consensus sequence T-X-Y-X-X-[VI] present in SLAM family receptors have overlapping specificity for activating and inhibitory SH2 domain-containing binding partners. Especially they mediate the interaction with the SH2 domain of SH2D1A and SH2D1B. For SLAMF1 a 'two-out-of-three-pronged' mechanism is proposed involving threonine (position -2), phosphorylated tyrosine (position 0) and valine/isoleucine (position +3). SH2D1A binding is mediated by either three 'prongs' (for high affinity binding involving ITSM 1) or a combination of any two also including non-phosphorylated Tyr-281 of ITSM 1 thus providing a positive feedback loop implicating SH2D1A-dependent recruitment of activating FYN. ITSM 2 needs to be phosphorylated on Tyr-327 for SH2D1A binding.</text>
</comment>
<comment type="PTM">
<text evidence="8 9">Phosphorylated on tyrosine residues by FYN.</text>
</comment>
<dbReference type="EMBL" id="U33017">
<property type="protein sequence ID" value="AAA75380.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="KF471075">
<property type="protein sequence ID" value="AHF72732.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL121985">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL138930">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471121">
<property type="protein sequence ID" value="EAW52706.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC132792">
<property type="protein sequence ID" value="AAI32793.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF252305">
<property type="protein sequence ID" value="AAG10434.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1207.1">
<molecule id="Q13291-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS81389.1">
<molecule id="Q13291-4"/>
</dbReference>
<dbReference type="PIR" id="S58892">
<property type="entry name" value="S58892"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001317683.1">
<molecule id="Q13291-4"/>
<property type="nucleotide sequence ID" value="NM_001330754.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003028.1">
<molecule id="Q13291-1"/>
<property type="nucleotide sequence ID" value="NM_003037.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005245513.1">
<molecule id="Q13291-3"/>
<property type="nucleotide sequence ID" value="XM_005245456.3"/>
</dbReference>
<dbReference type="PDB" id="1D4T">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.10"/>
<property type="chains" value="B=276-286"/>
</dbReference>
<dbReference type="PDB" id="1D4W">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="C/D=276-286"/>
</dbReference>
<dbReference type="PDB" id="1I3Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="B=273-286"/>
</dbReference>
<dbReference type="PDB" id="1KA6">
<property type="method" value="NMR"/>
<property type="chains" value="B=275-282"/>
</dbReference>
<dbReference type="PDB" id="1KA7">
<property type="method" value="NMR"/>
<property type="chains" value="B=275-286"/>
</dbReference>
<dbReference type="PDB" id="1M27">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="B=276-286"/>
</dbReference>
<dbReference type="PDB" id="2DZF">
<property type="method" value="Model"/>
<property type="chains" value="@=1-335"/>
</dbReference>
<dbReference type="PDB" id="2IE9">
<property type="method" value="Model"/>
<property type="chains" value="@=1-335"/>
</dbReference>
<dbReference type="PDB" id="2IFL">
<property type="method" value="Model"/>
<property type="chains" value="@=3-335"/>
</dbReference>
<dbReference type="PDB" id="2IG5">
<property type="method" value="Model"/>
<property type="chains" value="@=1-335"/>
</dbReference>
<dbReference type="PDBsum" id="1D4T"/>
<dbReference type="PDBsum" id="1D4W"/>
<dbReference type="PDBsum" id="1I3Z"/>
<dbReference type="PDBsum" id="1KA6"/>
<dbReference type="PDBsum" id="1KA7"/>
<dbReference type="PDBsum" id="1M27"/>
<dbReference type="PDBsum" id="2DZF"/>
<dbReference type="PDBsum" id="2IE9"/>
<dbReference type="PDBsum" id="2IFL"/>
<dbReference type="PDBsum" id="2IG5"/>
<dbReference type="SMR" id="Q13291"/>
<dbReference type="BioGRID" id="112395">
<property type="interactions" value="123"/>
</dbReference>
<dbReference type="DIP" id="DIP-40767N"/>
<dbReference type="ELM" id="Q13291"/>
<dbReference type="IntAct" id="Q13291">
<property type="interactions" value="63"/>
</dbReference>
<dbReference type="MINT" id="Q13291"/>
<dbReference type="STRING" id="9606.ENSP00000306190"/>
<dbReference type="GlyGen" id="Q13291">
<property type="glycosylation" value="8 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="Q13291"/>
<dbReference type="PhosphoSitePlus" id="Q13291"/>
<dbReference type="BioMuta" id="SLAMF1"/>
<dbReference type="DMDM" id="9297047"/>
<dbReference type="MassIVE" id="Q13291"/>
<dbReference type="PaxDb" id="Q13291"/>
<dbReference type="PeptideAtlas" id="Q13291"/>
<dbReference type="PRIDE" id="Q13291"/>
<dbReference type="ProteomicsDB" id="59283">
<molecule id="Q13291-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="59284">
<molecule id="Q13291-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="59285">
<molecule id="Q13291-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="3725">
<property type="antibodies" value="969 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="6504"/>
<dbReference type="Ensembl" id="ENST00000302035">
<molecule id="Q13291-1"/>
<property type="protein sequence ID" value="ENSP00000306190"/>
<property type="gene ID" value="ENSG00000117090"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000538290">
<molecule id="Q13291-4"/>
<property type="protein sequence ID" value="ENSP00000438406"/>
<property type="gene ID" value="ENSG00000117090"/>
</dbReference>
<dbReference type="GeneID" id="6504"/>
<dbReference type="KEGG" id="hsa:6504"/>
<dbReference type="UCSC" id="uc001fwl.6">
<molecule id="Q13291-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="UCSC" id="uc031vca.2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6504"/>
<dbReference type="DisGeNET" id="6504"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000117090.14"/>
<dbReference type="GeneCards" id="SLAMF1"/>
<dbReference type="HGNC" id="HGNC:10903">
<property type="gene designation" value="SLAMF1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000117090">
<property type="expression patterns" value="Tissue enriched (lymphoid)"/>
</dbReference>
<dbReference type="MIM" id="603492">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q13291"/>
<dbReference type="OpenTargets" id="ENSG00000117090"/>
<dbReference type="PharmGKB" id="PA35803"/>
<dbReference type="eggNOG" id="ENOG502SVMG">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00990000203564"/>
<dbReference type="HOGENOM" id="CLU_066453_0_0_1"/>
<dbReference type="InParanoid" id="Q13291"/>
<dbReference type="KO" id="K06536"/>
<dbReference type="OMA" id="CRTESKE"/>
<dbReference type="OrthoDB" id="1532935at2759"/>
<dbReference type="PhylomeDB" id="Q13291"/>
<dbReference type="TreeFam" id="TF334964"/>
<dbReference type="PathwayCommons" id="Q13291"/>
<dbReference type="SIGNOR" id="Q13291"/>
<dbReference type="BioGRID-ORCS" id="6504">
<property type="hits" value="11 hits in 873 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="SLAMF1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q13291"/>
<dbReference type="GeneWiki" id="SLAMF1"/>
<dbReference type="GenomeRNAi" id="6504"/>
<dbReference type="Pharos" id="Q13291">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q13291"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="Q13291">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000117090">
<property type="expression patterns" value="Expressed in thymus and 113 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q13291">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q13291">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0003823">
<property type="term" value="F:antigen binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0042169">
<property type="term" value="F:SH2 domain binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0001618">
<property type="term" value="F:virus receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002250">
<property type="term" value="P:adaptive immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007155">
<property type="term" value="P:cell adhesion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0046649">
<property type="term" value="P:lymphocyte activation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0002277">
<property type="term" value="P:myeloid dendritic cell activation involved in immune response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000349">
<property type="term" value="P:negative regulation of CD40 signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032695">
<property type="term" value="P:negative regulation of interleukin-12 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032715">
<property type="term" value="P:negative regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032720">
<property type="term" value="P:negative regulation of tumor necrosis factor production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006909">
<property type="term" value="P:phagocytosis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046330">
<property type="term" value="P:positive regulation of JNK cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR010407">
<property type="entry name" value="Sig_lymph_act_molc_N"/>
</dbReference>
<dbReference type="Pfam" id="PF06214">
<property type="entry name" value="SLAM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1064">Adaptive immunity</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0130">Cell adhesion</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-1183">Host cell receptor for virus entry</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0581">Phagocytosis</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="3">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="chain" description="Signaling lymphocytic activation molecule" id="PRO_0000014959">
<location>
<begin position="21"/>
<end position="335"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="3">
<location>
<begin position="21"/>
<end position="237"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="3">
<location>
<begin position="238"/>
<end position="258"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="3">
<location>
<begin position="259"/>
<end position="335"/>
</location>
</feature>
<feature type="domain" description="Ig-like V-type">
<location>
<begin position="29"/>
<end position="138"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type">
<location>
<begin position="144"/>
<end position="223"/>
</location>
</feature>
<feature type="short sequence motif" description="ITSM 1" evidence="9">
<location>
<begin position="279"/>
<end position="284"/>
</location>
</feature>
<feature type="short sequence motif" description="SH2-binding" evidence="3">
<location>
<begin position="307"/>
<end position="312"/>
</location>
</feature>
<feature type="short sequence motif" description="ITSM 2" evidence="22 23">
<location>
<begin position="325"/>
<end position="330"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by FYN" evidence="7 8">
<location>
<position position="281"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by FYN" evidence="8">
<location>
<position position="307"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by FYN" evidence="8">
<location>
<position position="327"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="53"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="57"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="102"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="125"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="150"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="155"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="189"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3">
<location>
<position position="217"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="158"/>
<end position="228"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="164"/>
<end position="209"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_002567" evidence="21">
<location>
<begin position="234"/>
<end position="263"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_058033" evidence="20">
<original>GKTNHYQTTVEKKSLTIYAQVQKPGPLQKKLDSFPAQDPCTTIYVAATEPVPESVQETNSITVYASVTLPES</original>
<variation>ATLTTTNQYWSQNVLTQDQERCPGCLPMVKRTITRQQWKKKALRSMPKSRNQVLFRRNLTPSQLRTLAPPYMLLPQSLSQSLSRKQIPSQSMLV</variation>
<location>
<begin position="264"/>
<end position="335"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_002568" evidence="21">
<original>PLQKKLDSFP</original>
<variation>DTHHQTSDLF</variation>
<location>
<begin position="289"/>
<end position="298"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_002569" evidence="21">
<location>
<begin position="299"/>
<end position="335"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2295612." id="VAR_021924">
<original>F</original>
<variation>L</variation>
<location>
<position position="11"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation; dbSNP:rs1373814964." id="VAR_035524" evidence="13">
<original>L</original>
<variation>F</variation>
<location>
<position position="81"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3796504." id="VAR_021925">
<original>P</original>
<variation>T</variation>
<location>
<position position="333"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with INPP5D/SHIP-1, PTPN11/SHP-2 and SH2D1A." evidence="6">
<original>Y</original>
<variation>F</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with SH2D1A; when associated with A-325." evidence="8">
<original>T</original>
<variation>A</variation>
<location>
<position position="279"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with INPP5D/SHIP-1 and PTPN11/SHP-2, no effect on interaction with SH2D1A." evidence="6 8">
<original>Y</original>
<variation>F</variation>
<location>
<position position="281"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with SH2D1A; when associated with F-327." evidence="8">
<original>Y</original>
<variation>F</variation>
<location>
<position position="281"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with PTPN11/SHP-2 and SH2D1A." evidence="6">
<original>Y</original>
<variation>F</variation>
<location>
<position position="307"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with SH2D1A; when associated with A-279." evidence="8">
<original>T</original>
<variation>A</variation>
<location>
<position position="325"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with INPP5D/SHIP-1 and PTPN11/SHP-2, no effect on interaction with SH2D1A." evidence="6 8">
<original>Y</original>
<variation>F</variation>
<location>
<position position="327"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with SH2D1A; when associated with F-281." evidence="8">
<original>Y</original>
<variation>F</variation>
<location>
<position position="327"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="278"/>
<end position="281"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1D4T"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QUM4"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255"/>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10972291"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11313386"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11689425"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11806999"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11823424"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12458214"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12545174"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16317102"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20231852"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20818396"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25710480"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7617038"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9091591"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9774102"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="25710480"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7617038"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="11313386"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="11806999"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="12458214"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="25710480"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="7617038"/>
</source>
</evidence>
<sequence length="335" mass="37231" checksum="BFB0F27EA31D8C04" modified="1996-11-01" version="1" precursor="true">MDPKGLLSLTFVLFLSLAFGASYGTGGRMMNCPKILRQLGSKVLLPLTYERINKSMNKSIHIVVTMAKSLENSVENKIVSLDPSEAGPPRYLGDRYKFYLENLTLGIRESRKEDEGWYLMTLEKNVSVQRFCLQLRLYEQVSTPEIKVLNKTQENGTCTLILGCTVEKGDHVAYSWSEKAGTHPLNPANSSHLLSLTLGPQHADNIYICTVSNPISNNSQTFSPWPGCRTDPSETKPWAVYAGLLGGVIMILIMVVILQLRRRGKTNHYQTTVEKKSLTIYAQVQKPGPLQKKLDSFPAQDPCTTIYVAATEPVPESVQETNSITVYASVTLPES</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

